Cargando…

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines

Detalles Bibliográficos
Autores principales:	Kunene, Khontile Nobuhle, Teo, Shyh Poh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OMJ 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189423/ https://www.ncbi.nlm.nih.gov/pubmed/37260541 http://dx.doi.org/10.5001/omj.2023.81

Ejemplares similares

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021)

Interpretation of Antigen-detection Rapid Diagnostic Tests (Ag-RDTs) Should Take into Account the Pre-test Probability of COVID-19 Infection
por: Teo, Shyh Poh
Publicado: (2022)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Physical activity in older people with cardiac co-morbidities
por: Liew, Jun–Ming, et al.
Publicado: (2018)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

Pharmacovigilance and Its Importance for Primary Health Care Professionals
por: Hamid, Asma A’tiyah Abdul, et al.
Publicado: (2022)

Atrial fibrillation in older patients—reducing stroke risk is not only about anticoagulation
por: Win, Nay Thu, et al.
Publicado: (2016)

Review of COVID-19 Vaccines and Their Evidence in Older Adults
por: Teo, Shyh Poh
Publicado: (2021)

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Global pharmacovigilance regulations: Call for re-harmonization
por: Singh, Ajay, et al.
Publicado: (2018)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts
por: Schor, Shayna H., et al.
Publicado: (2022)

A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization
por: Ho, Jamie S. Y., et al.
Publicado: (2020)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Changes in the patient call volume and call characteristics to an epileptologist during the COVID-19 pandemic
por: Sethi, Nitin K.
Publicado: (2021)

The Bayesian Model on Human Papillomavirus Vaccination in Italy Lacks Transparency
por: Garattini, Livio, et al.
Publicado: (2013)

Call to Action for Dengue Vaccine Failure
por: Mahalingam, Suresh, et al.
Publicado: (2013)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries
por: Khan, Zakir, et al.
Publicado: (2022)

Africa and monkeypox vaccinations: A call for action
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

The COVID-19 pandemic and physical activity during intermittent fasting, is it safe? A call for action
por: Akbari, Hesam Addin, et al.
Publicado: (2021)

COVID-19 Related Liver Injury: Call for International Consensus
por: Ye, Zheng, et al.
Publicado: (2020)

Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis()
por: Murarasu, Anne, et al.
Publicado: (2023)

Lack of transparency during the COVID-19 pandemic: Nurturing a future and more devastating crisis
por: Braillon, Alain
Publicado: (2020)

COVID-19 Health Policies: The Need for Transparent Data Sharing Between Scientists, Governments, and Policymakers
por: Chirico, Francesco, et al.
Publicado: (2022)

Role of a medical advisor in pharmacovigilance as a business support service
por: Dang, Amit, et al.
Publicado: (2015)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
por: Billany, Roseanne E., et al.
Publicado: (2021)

COVID-19 Prevention and Protecting Sex Workers: A Call to Action
por: Singer, Randi, et al.
Publicado: (2020)

Do not call it COVID-19, it might have been the second wave
por: Rühli, Frank, et al.
Publicado: (2020)

COVID-19 pandemic and the burn survivor community: A call for action()
por: Ryan, Colleen M., et al.
Publicado: (2021)

Late STEMI and NSTEMI Patients’ Emergency Calling in COVID-19 Outbreak
por: Trabattoni, Daniela, et al.
Publicado: (2020)

Staying True to the Calling of Geriatric Medicine Amid the Waves of COVID-19
por: Cheong, Chin Yee, et al.
Publicado: (2020)

Post-COVID-19 syndrome: A call for continuity of multidisciplinary care
por: Barros-Leite, B.R.A.F., et al.
Publicado: (2022)

Post-COVID-19 syndrome: A call for continuity of multidisciplinary care
por: Barros-Leite, B.R.A.F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qt4u6ova1sni536ok0b12qsh4s